Effectiveness of Myopia Control Interventions : A Comparison of Myopia Control in European Children, Adolescents and Young Adults With Defocus Incorporated Multiple Segments (DIMS) and Highly Aspherical Lenslets (HAL) Spectacles, Atropine, Lenses and Combined Treatments
NCT ID: NCT07120165
Last Updated: 2025-08-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
114 participants
OBSERVATIONAL
2024-10-20
2025-05-07
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Several treatment options are available today, including pharmacological treatments with atropine eye drops, as well as optical myopia control systems in the form of glasses or contact lenses.
These different treatments have been used in clinical practice at Saint-Étienne University Hospital since 2017 for atropine, and more recently with the development of optical myopia control systems and their combinations.
Little clinical data has been published to date on these different treatment combinations in the French population.
The investigators would therefore like to set up a database to publish their results and share their experience.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Myopia Control in Children: Comparison of Defocus Incorporated Multiple Segments® Lenses Versus Atropine 0.05% Eyedrops
NCT05062031
3D Designed Defocus Lenses on Myopia Control in Children and Adolescents
NCT07284147
Topical 0.01% Atropine for the Control of Fast Progressing Myopia
NCT04173780
A RCT of Spectacles With Aspherical Lenslets or 0.05% Atropine for Myopia Control
NCT07095894
Different Microlenses Array for Controlling Myopia Progression in Children and Adolescents
NCT06926556
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Atropine 0.01%
Children or young adults with active myopia treated with ATROPINE 0.01% eye drops.
Demographic data collection
Demographic data collection: age, gender, level of education/study, time spent in near vision, sports practice, medical history
Ophthalmological history
Ophthalmological history: age of myopia discovery, parental refraction, previous refractions, presence of a braking treatment
Ophthalmological data at each examination
Ophthalmological data at each examination: visual acuity, subjective refraction, cycloplegia with SKIACOL, axial length.
Potential adverse events
Potential adverse events: halos, photophobia, stinging, infections, etc.
DIMS/HAL
Children or young adults with active myopia treated with myopia control glasses.
Demographic data collection
Demographic data collection: age, gender, level of education/study, time spent in near vision, sports practice, medical history
Ophthalmological history
Ophthalmological history: age of myopia discovery, parental refraction, previous refractions, presence of a braking treatment
Ophthalmological data at each examination
Ophthalmological data at each examination: visual acuity, subjective refraction, cycloplegia with SKIACOL, axial length.
Potential adverse events
Potential adverse events: halos, photophobia, stinging, infections, etc.
Various combined treatments
Children or young adults with active myopia treated with ATROPINE 0.01% eye drops or myopia control glasses or contact lenses, and their various combinations.
Demographic data collection
Demographic data collection: age, gender, level of education/study, time spent in near vision, sports practice, medical history
Ophthalmological history
Ophthalmological history: age of myopia discovery, parental refraction, previous refractions, presence of a braking treatment
Ophthalmological data at each examination
Ophthalmological data at each examination: visual acuity, subjective refraction, cycloplegia with SKIACOL, axial length.
Potential adverse events
Potential adverse events: halos, photophobia, stinging, infections, etc.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Demographic data collection
Demographic data collection: age, gender, level of education/study, time spent in near vision, sports practice, medical history
Ophthalmological history
Ophthalmological history: age of myopia discovery, parental refraction, previous refractions, presence of a braking treatment
Ophthalmological data at each examination
Ophthalmological data at each examination: visual acuity, subjective refraction, cycloplegia with SKIACOL, axial length.
Potential adverse events
Potential adverse events: halos, photophobia, stinging, infections, etc.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* patient affiliated with a social security organization
* agreement of both parents or the patient if adult
Exclusion Criteria
25 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Universitaire de Saint Etienne
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Marie-Caroline TRONE, Md
Role: PRINCIPAL_INVESTIGATOR
CHU de Saint-Étienne
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU de Saint-Étienne
Saint-Etienne, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRBN1022025/CHUSTE
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.